Professor Küster (*1967) conducts research in the fields of chemical proteomics and precision medicine. Together with an interdisciplinary team of biochemists, molecular biologists and bioinformaticians, he deals with questions about how exactly therapeutic drugs work, which molecular mechanisms play a role in cancer and how these can be used for individual approaches in clinical treatment.
After studying chemistry at the University of Cologne, Professor Küster completed his doctorate in biochemistry at the University of Oxford. He then worked as a postdoctoral researcher in Heidelberg and Odense, Denmark. Before taking up a full professorship at TUM in 2007, he was Vice President of Cellzome (now GSK). Professor Küster is Director of the Bavarian Biomolecular Mass Spectrometry Center and Co-Director of the Center for Infection Prevention. Professor Küster is co-founder of the biotech companies OmicScouts and MSAID.
